CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,115,043 | -7.2% | 1,932,153 | +32.7% | 0.11% | -18.2% |
Q4 2022 | $8,748,090 | +21.0% | 1,455,589 | -41.4% | 0.14% | +67.1% |
Q3 2022 | $7,231,224 | -5.7% | 2,482,622 | +93.3% | 0.08% | -46.1% |
Q2 2022 | $7,667,000 | +65.0% | 1,284,325 | +29.0% | 0.15% | +171.4% |
Q1 2022 | $4,648,000 | +63.7% | 995,280 | -13.1% | 0.06% | +180.0% |
Q4 2021 | $2,840,000 | -15.2% | 1,145,280 | +0.8% | 0.02% | -31.0% |
Q3 2021 | $3,351,000 | +36.9% | 1,136,049 | +16.1% | 0.03% | +31.8% |
Q2 2021 | $2,447,000 | -24.4% | 978,679 | -12.0% | 0.02% | -38.9% |
Q1 2021 | $3,235,000 | +1.5% | 1,111,680 | +12.3% | 0.04% | +28.6% |
Q4 2020 | $3,187,000 | +92.3% | 989,602 | +28.4% | 0.03% | -15.2% |
Q3 2020 | $1,657,000 | +3665.9% | 770,731 | +6761.3% | 0.03% | +1000.0% |
Q1 2018 | $44,000 | – | 11,233 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
FNY Investment Advisers, LLC | 20 | $0 | 0.00% |